middle.news
Mayne Pharma Acquisition Faces FIRB Delay: What’s Next for Shareholders?
3:52pm on Thursday 16th of October, 2025 AEDT
•
Pharmaceuticals
Read Story
Mayne Pharma Acquisition Faces FIRB Delay: What’s Next for Shareholders?
3:52pm on Thursday 16th of October, 2025 AEDT
Key Points
FIRB decision delayed beyond scheduled court hearing date
Second Court Hearing set for 22 October may be rescheduled
FIRB approval expected before 31 October 2025
Mayne Pharma advises shareholders no immediate action required
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE